Altering the Brain's Chemistry to Elevate Mood

Apocalypse Suicide Page
Good Mood
Living with Depression
Mental Health Recovery
NIMH
SHOCKED! ECT

HealthyPlace.com Radio
Depression Support Groups

Books on Depression
Conference Transcripts
Depression Videos
Diaries - Journals
Disorders Definitions
Mental Health News
Online Depression Tests
Psychiatric Medications
Resources
Site Map

Email
ICQ
Instant Messenger

Visit and Post

Abuse
ADD/ADHD
Addictions
Anxiety-Panic
Bipolar
Eating Disorders
Personality Disorders
Self-Injury

send this page to a friend

Altering the Brain's Chemistry
to Elevate Mood

By Donald Brown, N.D., Alan R. Gaby, M.D., and Ronald Reichert, N.D.

References For Above Story

Risby ED, et al. Mood disorders. In: Stoudemire A, editor. Clinical psychiatry for medical students. 2nd ed. New York: J.B. Lippincott Co.; 1994. p 198.
El-Mallakh RS, et al. Clues to depression in primary practice. Postgrad Med 1996;100:85.
Freeman PS, et al. Psychopathology. In: Sierles FS, editor. Behavioral science for medical students. Baltimore: Williams and Wilkins; 1993. p 253.
Rush AJ, et al. Neurobiological basis for psychiatric disorders. In: Rosenberg RN, editor. Comprehensive neurology. New York: Raven Press; 1991. p 563.
Goldberg IK. L-tyrosine in depression. Lancet 1980;2:364.
Gelenberg AJ, et al. Tyrosine treatment of depression. Am J Psychiatry 1980;137:622-3.
Sabelli HC, et al. Clinical studies on the phenylethylamine hypothesis of affective disorder: urine and blood phenylacetic acid and phenylalanine dietary supplements. J Clin Psychiatry 1986;47:66-70.
Hawkins WW, Barsky J. An experiment on human vitamin B6 deprivation. Science 1948;108:284-6.
Azuma J, et al. Apparent deficiency of vitamin B6 in typical individuals who commonly serve as normal controls. Res Commun Chem Pathol Pharmacol 1976;14:343-8.
Stewart JW, et al. Low B6 levels in depressed outpatients. Biol Psychiatry 1984;19:613-6.
Russ CS, et al. Vitamin B6 status of depressed and obsessive-compulsive patients. Nutr Rep Int 1983;27:867-73.
Adams PW, et al. Effect of pyridoxine hydrochloride (vitamin B6) upon depression associated with oral contraceptives. Lancet 1973;1:897-904.
Howard JS III. Folate deficiency in psychiatric practice. Psychosomatics 1975;16:112-5.
Ghadirian AM, et al. Folic acid deficiency and depression. Psychosomatics 1980;21:926-9.
Hector M, Burton JR. What are the psychiatric manifestations of vitamin B12 deficiency? J Am Geriatr Soc 1988;36:1105-12.
Geagea K, Ananth J. Response of a psychiatric patient to vitamin B12 therapy. Dis Nerv Syst 1975;35:343-4.
Daynes G. Cyanocobalamin in postpartum psychosis. S Afr Med J 1975;49:1373.
Cooper JR. The role of ascorbic acid in the oxidation of tryptophan to 5-hydroxytryptophan. Ann NY Acad Sci 1961;92:208-11.
Milner G. Ascorbic acid in chronic psychiatric patients: a controlled trial. Br J Psychiatry 1963;109:294-9.
Freyre AV, Flichman JC. Spasmophilia caused by magnesium deficit. Psychosomatics 1970;11:500-2.
Frizel D, et al. Plasma magnesium and calcium in depression. Br J Psychiatry 1969;115:1375-7.
Shealy CN, et al. Magnesium deficiency in depression and chronic pain. Magnesium Trace Elem 1990;9:333.
Facchinetti F, et al. Oral magnesium successfully relieves premenstrual mood changes. Obstet Gynecol 1991;78:177-81.
Morgan KJ, et al. Magnesium and calcium dietary intakes of the U.S. population. J Am Coll Nutr 1985;4:195-206.
Singh A, et al. Magnesium, zinc, and copper status of US Navy SEAL trainees. Am J Clin Nutr 1989;49:695-700.
Holzl J, et al. Investigations about antidepressive and mood changing effects of Hypericum perforatum. Planta Med 1989;55:643.
Muller WE, Rossol R. Effects of Hypericum extract on the expression of serotonin receptors. J Geriatr Psychiatry Neurol 1994;7(Suppl 1):S63-4.
Holzl J. Constituents and mechanism of action of St. John's wort. Zeitschrift Phytother 1993;14:255-64.
Ernst E. St. John's wort, an antidepressant? A systemic, criteria-based review. Phytomedicine 1995;2:67-71.
Monograph, Hyperici herba (St. John's wort), Bundesanzeiger 1984 Dec 5.
Lesser IM, et al. Reduction in cerebral blood flow in older depressed patients. Arch Gen Psychiatry 1994;51:677-86.
Schubert H, Halama P. Depressive episode primarily unresponsive to therapy in elderly patients: efficacy of Ginkgo biloba extract (EGb 761) in combination with antidepressants. Geriatr Forsch 1993;3:45-53.

advertisement

References For Story On 5-HTP and the Serotonin Connection

1. Poldinger W, et al. A functional-dimensional approach to depression: serotonin deficiency as a target syndrome in a comparison of 5-hydroxytryptophan and fluvoxamine. Psychopathology 1991;24:53-81.

2. Zmilacher K, et al. L-5-hydroxytryptophan alone and in combination with a peripheral decarboxylase inhibitor in the treatment of depression. Neuropsychobiology 1988;20:28-35.

3. van Praag H. Management of depression with serotonin precursors. Biol Psychiatry 1981;16:291-310.

4. Byerley W, et al. 5-hydroxytryptophan: a review of its antidepressant efficacy and adverse effects. J Clin Psychopharmacol 1987;7:127.

5. Physician's Desk Reference. 49th ed. Montvale, NJ: Medical Economics Data Production Company; 1995.

6. Caruso I, et al. Double-blind study of 5-hydroxytryptophan versus placebo in the treatment of primary fibromyalgia syndrome. J Int Med Res 1990;18:201-9.

7. Cangiano C, et al. Eating behavior and adherence to dietary prescriptions in obese adult subjects treated with 5-hydroxytryptophan. Am J Clin Nutr 1992;56:863-7.

8. Maissen CP, et al. Comparison of the effect of 5-hydroxytryptophan and propranolol in the interval treatment of migraine. Schweiz Med Wochenschr 1991;121:1585-90.

Altering the Brain's Chemistry to Elevate Mood

References For Above Story

References For Story On 5-HTP and the Serotonin Connection

RELATED LINKS AND INFO

Altering the Brain's Chemistry
to Elevate Mood